PL2044099T3 - Sposób wytwarzania S-fluorometylo-6,9-difluoro-11-hydroksy-16-metylo-17-propionyloksy-3-okso-androsta-1,4-dieno-17-karbotionianu oraz związki pośrednie - Google Patents

Sposób wytwarzania S-fluorometylo-6,9-difluoro-11-hydroksy-16-metylo-17-propionyloksy-3-okso-androsta-1,4-dieno-17-karbotionianu oraz związki pośrednie

Info

Publication number
PL2044099T3
PL2044099T3 PL07733749T PL07733749T PL2044099T3 PL 2044099 T3 PL2044099 T3 PL 2044099T3 PL 07733749 T PL07733749 T PL 07733749T PL 07733749 T PL07733749 T PL 07733749T PL 2044099 T3 PL2044099 T3 PL 2044099T3
Authority
PL
Poland
Prior art keywords
carbothioate
androsta
propionyloxy
fluoromethyl
difluoro
Prior art date
Application number
PL07733749T
Other languages
English (en)
Inventor
Vinayak G Gore
Mahesh Gadakar
K Pokharkar
V Wakchure
Original Assignee
Generics Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Generics Uk Ltd filed Critical Generics Uk Ltd
Publication of PL2044099T3 publication Critical patent/PL2044099T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL07733749T 2006-06-14 2007-06-11 Sposób wytwarzania S-fluorometylo-6,9-difluoro-11-hydroksy-16-metylo-17-propionyloksy-3-okso-androsta-1,4-dieno-17-karbotionianu oraz związki pośrednie PL2044099T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN937MU2006 2006-06-14
IN938MU2006 2006-06-14
EP07733749A EP2044099B1 (en) 2006-06-14 2007-06-11 Process for the preparation of s-fluoromethyl-6 ,9 -difluoro-11 -hydroxy-16 -methyl-17 -propionyloxy-3-oxo-androsta-1,4-diene-17 -carbothioate and intermediates
PCT/GB2007/050328 WO2007144668A2 (en) 2006-06-14 2007-06-11 Process for the preparation of s-fluoromethyl-6, 9 -difluoro-11 -hydroxy-16 -methyl-17-propionyloxy-3-oxo-androsta-1,4-diene-17 -carbothioate and intermediates

Publications (1)

Publication Number Publication Date
PL2044099T3 true PL2044099T3 (pl) 2012-10-31

Family

ID=38537615

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07733749T PL2044099T3 (pl) 2006-06-14 2007-06-11 Sposób wytwarzania S-fluorometylo-6,9-difluoro-11-hydroksy-16-metylo-17-propionyloksy-3-okso-androsta-1,4-dieno-17-karbotionianu oraz związki pośrednie

Country Status (11)

Country Link
US (2) US8344168B2 (pl)
EP (3) EP2044099B1 (pl)
AU (1) AU2007258949B2 (pl)
CA (2) CA2654644C (pl)
CY (1) CY1113046T1 (pl)
DK (1) DK2044099T3 (pl)
ES (1) ES2388307T3 (pl)
PL (1) PL2044099T3 (pl)
PT (1) PT2044099E (pl)
SI (1) SI2044099T1 (pl)
WO (1) WO2007144668A2 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3517541T (pt) 2012-05-08 2020-08-28 Nicox Ophthalmics Inc Forma polimórfica de propionato de fluticasona
US8765725B2 (en) 2012-05-08 2014-07-01 Aciex Therapeutics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
US9815865B2 (en) 2013-01-07 2017-11-14 Nicox Ophthalmics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
US9303060B1 (en) 2014-10-03 2016-04-05 Amphaster Pharmaceuticals, Inc. Methods of preparing intermediate of fluticasone propionate
CN110759960B (zh) * 2019-10-30 2021-03-23 山东赛托生物科技股份有限公司 一种丙酸氟替卡松的精制方法
CN114685593B (zh) * 2020-12-31 2024-01-23 鲁南制药集团股份有限公司 一种氟维司群制备方法及其中间体
CN118746629B (zh) * 2024-06-18 2025-01-24 山东京卫制药有限公司 一种检测丙酸氟替卡松中间体硫代羧酸有关物质的分析方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2629752A (en) * 1951-12-27 1953-02-24 Gen Aniline & Film Corp Preparation and purification of 1-phenylbutadiene-1, 3
CA1201114A (en) * 1980-02-15 1986-02-25 Gordon H. Phillipps Androstane carbothioates
CY1291A (en) * 1980-02-15 1985-10-18 Glaxo Group Ltd Androstane 17 beta carbothioates
IL109656A (en) 1994-05-15 1998-02-22 Chemagis Ltd Process for the manufacture of androstane - 17 - carbothioates and androstane - 17 - carbothioates prepared thereby
GB9828721D0 (en) * 1998-12-24 1999-02-17 Glaxo Group Ltd Novel apparatus and process
US20020133032A1 (en) 2000-02-25 2002-09-19 Jufang Barkalow Method for the preparation of fluticasone and related 17beta-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods
GB0202564D0 (en) * 2002-02-04 2002-03-20 Glaxo Group Ltd Process
US7208613B2 (en) 2002-06-20 2007-04-24 Sun Pharmaceutical Industries Limited Synthesis of s-fluoromethyl 6α,9α-difluoro-11β-hydroxy-16α-methyl-17α-propionyloxy-3-oxoandrosta-1,4-diene-17β-carbothioate
ITMI20022606A1 (it) * 2002-12-09 2004-06-10 Farmabios Spa Processo di sintesi di steroidi polialogenati.
IL153462A0 (en) 2002-12-16 2003-07-06 Chemagis Ltd Thiocarboxylic acid organic salts and processes utilizing the same
EP1526139A1 (en) * 2003-10-24 2005-04-27 S.N.I.F.F. Italia S.P.A. A process for preparing highly pure androstane 17-beta-carboxylic acids and androstane 17-beta-carbothioic acid fluoromethyl esters
WO2007009954A1 (en) 2005-07-20 2007-01-25 Shell Internationale Research Maatschappij B.V. Method to start a process for hydrocarbon synthesis
AR059216A1 (es) * 2006-01-27 2008-03-19 Sun Pharmaceutical Ind Ltd 11b-hidroxiandrosta-4-eno-3-onas

Also Published As

Publication number Publication date
CY1113046T1 (el) 2016-04-13
EP2044099A2 (en) 2009-04-08
CA2654644A1 (en) 2007-12-21
EP2402361B1 (en) 2020-04-15
EP2044099B1 (en) 2012-05-23
DK2044099T3 (da) 2012-07-02
US20090177001A1 (en) 2009-07-09
AU2007258949B2 (en) 2013-02-21
EP2402361A1 (en) 2012-01-04
PT2044099E (pt) 2012-06-06
US20130172587A1 (en) 2013-07-04
US8344168B2 (en) 2013-01-01
CA2654644C (en) 2014-02-18
CA2835790A1 (en) 2007-12-21
WO2007144668A2 (en) 2007-12-21
EP2402360B1 (en) 2020-04-01
SI2044099T1 (sl) 2012-09-28
WO2007144668A3 (en) 2008-02-28
CA2835790C (en) 2017-05-16
ES2388307T3 (es) 2012-10-11
EP2402360A1 (en) 2012-01-04
AU2007258949A1 (en) 2007-12-21

Similar Documents

Publication Publication Date Title
DK3872059T3 (en) Process for the preparation of 2,3,3,3 tetrahydrofluoropropene
IL202664A (en) Processes for Preparation of 3-Dihlomethyl-1-Methyl-1H-Pyrazole-4-Carbaldehyde and Intermediates
SG10201508066VA (en) Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto
SI2155699T1 (sl) Ariloazol-2-il cianoetilamino spojine, postopek njihove izdelave in postopek njihove uporabe
IL200520A (en) A process for making certain conserved sulfylamines
IL196875A0 (en) Process for the preparation of 2-substituted-5-(1-alkylthio)alkylpyridines
IL198847A0 (en) New process for the preparation of 2-imino-thiazolidin-4-one derivatives
ZA200903533B (en) Process for the preparation of rosuvastatin
IL198117A0 (en) Process for preparing indol-5-oxy-quinazoline derivatives and intermediates
IL185627A (en) A process for making alkyl-anilides and their intermediates
ZA200907191B (en) Process for the preparation of gefitiib
IL196481A0 (en) Process for the preparation of levetiracetam
ZA200804264B (en) Process for the preparation of ferri-succinylcasein
IL197954A0 (en) Process for the preparation of imatinib and intermediates thereof
SI2044099T1 (sl) Postopek priprave S-fluorometil-6,9-difluoro-11-hidroksi-16-metil-17-propioniloksi-3-okso -androsta-1,4-dien-17-karbotioata in vmesnih spojin
IL184715A0 (en) Process for the preparation of intermediates
IL200850A0 (en) Process for the preparation of entacapone and intermediates thereof
GB0910201D0 (en) The preparation method of 2-deoxy-l-ribose
EP1996192A4 (en) PROCESS FOR PREPARING 3,4-SUBSTITUTED THIAZOLIDIN-2-ONES IN 3,4
ZA200601910B (en) Process for the preparation of organosilances
PL1937626T3 (pl) Sposób i związki do otrzymywania salmeterolu
ZA201003264B (en) Method for the preparation of 2 chloro1,1,1,2,3,3,3 heptafluopropane
PL1940387T3 (pl) Sposób stereoselektywnego wytwarzania (-)-halofenatu i jego półproduktów
HUP0600946A2 (en) Process for the preparation of duloxetine and the new intermediates
EP1915380A4 (en) PROCESS FOR THE SYNTHESIS OF N, N'-DISUBSTITUTED OXABISPIDINES